866
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment

, , , , , & show all
Pages 288-295 | Received 01 Sep 2023, Accepted 15 Nov 2023, Published online: 02 Dec 2023

References

  • Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770. doi: 10.1016/S0140-6736(16)32126-2
  • Bohm M, Xu R, Zhang Y, et al. Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for crohn’s disease. Aliment Pharmacol Ther. 2020;52(4):669–681. doi: 10.1111/apt.15921
  • Lasa JS, Olivera PA, Danese S, et al. Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(2):161–170. doi: 10.1016/S2468-1253(21)00377-0
  • Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003;114(1):39–43. doi: 10.1016/s0002-9343(02)01383-9
  • Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by crohn’s disease patients. Adv Ther. 2009;26(10):936–946. doi: 10.1007/s12325-009-0069-7
  • Carter CT, Leher H, Smith P, et al. Impact of persistence with infliximab on hospitalizations in ulcerative colitis. Am J Manag Care. 2011;17:385–392
  • Greenfield S, Kaplan SH, Ware JE, Jr., et al. Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3(5):448–457. doi: 10.1007/BF02595921
  • Street RL, Jr., Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making. 1997;17(3):298–306. doi: 10.1177/0272989X9701700306
  • Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics. 2008;26(8):661–677. doi: 10.2165/00019053-200826080-00004
  • Opuni M, Bishai D, Gray GE, et al. Preferences for characteristics of antiretroviral therapy provision in johannesburg, South Africa: results of a conjoint analysis. AIDS Behav. 2010;14(4):807–815. doi: 10.1007/s10461-009-9584-4
  • Fraenkel L. Conjoint analysis at the individual patient level: issues to consider as we move from a research to a clinical tool. Patient. 2008;1(4):251–253. doi: 10.2165/1312067-200801040-00005
  • Nathan H, Bridges JF, Schulick RD, et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011;29(6):619–625. doi: 10.1200/JCO.2010.30.8650
  • Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–413. doi: 10.1016/j.jval.2010.11.013
  • de Bekker-Grob EW, Donkers B, Jonker MF, et al. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–384. doi: 10.1007/s40271-015-0118-z
  • Pearmain D, Kroes EP. Stated preference techniques: a guide to practice1990
  • Schubert S, Picker N, Cavlar T, et al. Inflammatory bowel disease patients’ treatment preferences using a discrete choice experiment technique: the InPuT study. Adv Ther. 2022;39(6):2889–2905. doi: 10.1007/s12325-022-02143-z
  • Wickramasekera N, Coates E, Barr A, et al. Patient preferences for treatment in steroid resistant ulcerative colitis - a discrete-choice experiment. Scand J Gastroenterol. 2022;57(7):797–806. doi: 10.1080/00365521.2022.2036808
  • Schoefs E, Vermeire S, Ferrante M, et al. What are the unmet needs and most relevant treatment outcomes according to patients with inflammatory bowel disease? A qualitative patient preference study. J Crohns Colitis. 2023;17(3):379–388.2022
  • Bewtra M, Fairchild AO, Gilroy E, et al. Inflammatory bowel disease patients’ willingness to accept medication risk to avoid future disease relapse. Am J Gastroenterol. 2015;110(12):1675–1681. doi: 10.1038/ajg.2015.321
  • Almario CV, Keller MS, Chen M, et al. Optimizing selection of biologics in inflammatory bowel disease: development of an online patient decision aid using conjoint analysis. Am J Gastroenterol. 2018;113(1):58–71. doi: 10.1038/ajg.2017.470
  • Durand C, Eldoma M, Marshall DA, et al. Patient preferences for disease-modifying antirheumatic drug treatment in rheumatoid arthritis: a systematic review. J Rheumatol. 2020;47(2):176–187. doi: 10.3899/jrheum.181165
  • Byrne CM, Tan KK, Young JM, et al. Patient and clinician preferences for surgical and medical treatment options in ulcerative colitis. Colorectal Dis. 2014;16(4):285–292. doi: 10.1111/codi.12538
  • Kelstrup AM, Juillerat P, Korzenik J. The accuracy of self-reported medical history: a preliminary analysis of the promise of internet-based research in inflammatory bowel diseases. J Crohns Colitis. 2014;8(5):349–356. doi: 10.1016/j.crohns.2013.09.012